MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) today announced that Mr. Donald Santel, former Chief Executive Officer of CoTherix Inc., has joined the company’s Board of Directors. Mr. Santel is an experienced senior executive and director with more than 25 years experience in the biotechnology, pharmaceutical and medical device industries.
